Daiichi Sankyo Expands To China's Low-tier Cities Through Local Partner Rundu
This article was originally published in PharmAsia News
Executive Summary
After recently gaining entry to China for Ranbaxy generics, Daiichi Sankyo is now looking beyond China's largest cities for untapped growth.